🚨BREAKING: Validic Acquired by ChartSpan PLUS ✨Exclusive ✨Interview with Drew Schiller (Validic CEO)
Validic Acquired by ChartSpan to Create the Industry’s Leading Platform for Data-Driven, Cost-Effective Clinical Care. NC Tweener Fund Invested in Q4 2022.
We have an exclusive 👀first look 👀 at a big acquisition announced this morning. Before we dig into the press release, here’s an exclusive interview we had with Validic’s CEO Drew Schiller (15mins).
From the press release here’s the ChartSpan rationale for the deal:
“Healthcare has historically made decisions based on snapshots of patient health,” said Christine Hawkins, Chief Executive Officer of ChartSpan. “By combining Validic’s personal health data infrastructure with ChartSpan’s clinical services, we’re helping healthcare organizations move from periodic observation to continuous understanding: identifying risk earlier, intervening sooner, and improving outcomes while lowering costs at scale. This partnership lays the foundation to turn health data into high-precision clinical action at every step of a patient’s journey, giving our customers the tools to stay ahead of both acute episodes and chronic disease progression for every patient they serve.”
Drew chimed in:
“For over a decade, Validic has worked to make personal health data accessible and actionable within healthcare,” said Drew Schiller, Chief Executive Officer of Validic. “We’ve long believed that some of the most important indicators of health exist beyond the walls of the clinic. By joining ChartSpan, we’re combining continuous patient insight with proven clinical services, creating new opportunities for healthcare organizations to identify risk earlier, personalize interventions, and improve outcomes for the populations they serve.”
Thanks to our Sponsors!
Breaking news like this wouldn’t be possible without the generous support of our sponsors:
Featured Platinum Sponsor
Featured Silver Sponsor
Advisors
Oppenheimer & Co. Inc. served as financial advisor to Validic in connection with the transaction. BIP Capital led the financing for ChartSpan, with Managing Partner and CEO Mark Buffington and Principal RT Wyatt leading the firm’s efforts.
About ChartSpan
ChartSpan is a leading care management company dedicated to scaling the impact of preventive care. Through specialized clinical services, expert care teams, and supportive technology infrastructure, ChartSpan helps organizations improve patient outcomes, increase revenue, and reduce the burden of chronic disease. For more information, visit www.chartspan.com.